Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 101 for “"cTnI"”.
-
Η διαγνωστική αξία της τροπονίνης cTnI στη μεταθανάτια διάγνωση του εμφράγματος του μυοκαρδίου
… pressure gradient. Furthermore, the levels of cTnI remain elevated for 6 days after the onset of clinical symptoms of acute myocardial infarction. The aim of this study is to compare the levels of post mortem concentration of cTnI in the pericardial fluid between groups of cases due to various …
-
sST2 as a candidate for dual biosensing with cTnI in presentations of myocardial infarction
… spinout), where a duplex assay for sST2 and cTnI was created, enabling a rapid solution for measuring both biomarkers simultaneousl<br><br>Chapter 2 describes the optimisation of this complex assay in 96-well plate ELISA format with novel techniques for improving sensitivity and specificity …
-
Παρακολούθηση της hs-cTnI (τροπονίνης) στον καρκίνο του πνεύμονα πριν και μετά την ανοσοθεραπεία-προγνωστική σημασία της θετικής της κίνησης
… Η καρδιακή τροπονίνη Ι υψηλής ευαισθησίας (hs-cTnI), ένας γνωστός δείκτης καρδιοτοξικότητας, αναδύεται ως πιθανός προγνωστικός παράγοντας της συνολικής επιβίωσης στην ογκολογία. Στόχοι: Αυτή η αναδρομική μελέτη αποσκοπούσε στην αξιολόγηση της προγνωστικής αξίας της hs-cTnI σε ασθενείς με …
-
Autoantikörper gegen kardiales Troponin I im Vergleich zu kardialem Troponin I und NT-proBNP bei älteren Patienten mit chronischer Herzinsuffizienz und Betarezeptorblockertherapie
… Ziel dieser Studie war es die Bedeutung der Anti-cTnI an einem gut definierten Patientenkollektiv mit einer Herzinsuffizienz zu evaluieren. Die Veränderungen der Anti-cTnI in der Korrelation zu NT-proBNP und cTnI wurden im Rahmen einer ß-Blocker-Therapie bei älteren, chronisch herzinsuffizienten …
-
Development of Magnetic Nanoparticle-based Enrichment Techniques and Mass Spectrometry Methods for Quantification of the Clinical Biomarker Cardiac Troponin I
Human cardiac troponin I (cTnI) in serum is a well-known clinical biomarker for cardiac tissue damage and is used for diagnosing myocardial infarction. Unfortunately, commercial cTnI immunoassays from different manufacturers can produce significantly different measurement results for the same …
-
Cardiac biomarkers, acute phase proteins and survival in small animals
… the association between cardiac troponin I (cTnI) and survival in dogs and cats with cardiac disease and one prospective study exploring the relationship between cTnI, B-type prohormone natriuretic peptide (NT-proBNP) and acute phase proteins (APP) in cats with cardiac and non-cardiac …
-
Der Stellenwert der Troponin-I-(cTnl)- und Troponin-T-(cTnT)-Bestimmung in der Risikostratifizierung von Patienten mit akuter Lungenembolie
… eine Herausforderung. <br>Kardiales Troponin I (cTnI) und T (cTnT) sind zuverlässige Indikatoren für eine Schädigung des Myokards und können mit einer rechtsventrikulären Dysfunktion bei einer Lungenembolie assoziiert sein. <br>Methoden und Ergebnisse - Die vorliegende prospektive Studie …
-
USE OF HIGH-SENSITIVITY CARDIAC TROPONINS TO IMPROVE POPULATION RISK STRATIFICATION
… High-sensitivity cardiac troponin I (hs-cTnI) and T (hs-cTnT) detect circulating concentrations in 50-100% of the general ambulatory population and reflect chronic cardiac damage. Recent population studies suggest hs-cTnI and hs-cTnT are only moderately correlated with one another and …
-
Kardiales Troponin I bei Hunden mit systemischem Entzündungssyndrom (SIRS)
… injury can be detected by cardiac troponin I (cTnI) concentrations, which appears to be a predictor of short-term death in critically ill patients. It is unknown if the best prognostic indicator of short-term survival is cTnI measurement at admission or at later time points. …
-
Hochsensitives Troponin in Diagnostik, Risikostratifizierung und Prognose bei Patienten mit akuten kardiovaskulären Erkrankungen in der Notaufnahme
… weitere Daten zum klinischen Nutzen von hs cTnI sowie zur Wertigkeit von hs cTnI in der Prognostik bei Patienten mit akuten kardiovaskulären Symptomen in der Notaufnahme hervorzubringen. Methoden: Es wurden 537 Patienten mit den kardiovaskulären Leitsymptomen Brustschmerz und Dyspnoe …
-
Cardiac Troponin I in Standardbred Racehorses
We investigated the use of cardiac troponin I (cTnI) assays in horses and their application in detection of exercise-associated myocardial damage. Available assays were designed for use in humans; therefore, study phase I involved analytical validation of current assays in the horse. Linearity, …
-
The Effects Of The N-Terminal Extensions Of Cardiac Troponins On The Ca2+ Regulation Of Myosin Atpase Kinetics In Cardiac Myofibrils
… The cardiac troponin subunits T (cTnT) and I (cTnI) have unique N-terminal extensions that can be selectively removed by restrictive proteolysis during cardiac adaptation to physiological and pathological stresses, indicating a role of these proteins in modulating cardiac contraction. This …
-
Η χρήση της καρδιακής τροπονίνης Ι ως προγνωστικού δείκτη σε ασθενείς που υποβάλλονται σε αορτοστεφανιαία παράκαμψη
… concentrations of Cardiac Troponin I (cTnI) may increase in patients undergoing aorto-coronary bypass grafting (CABG). The degree and pattern of release appears to be associated with perioperative myocardial damage. Postoperative cardiac troponin elevation may also be associated with …
-
Characterization of Maturity Marker Cardiac Troponin I in Human-Induced Pluripotent Stem Cell-Derived Cardiac Myocytes
… isoform switch between cardiac troponin I (cTnI) and slow-skeletal troponin I (ssTnI) is used to increase cTnI expression levels in the hiPSC-CMs. Promising results were found in all cases, with the adenovirus transduction of cTnI and the transfection of antisense oligonucleotides (ASOs) …
-
Cardiac Biomarkers in Hyperthyroid Cats
… The cardiac biomarkers NT-proBNP and troponin I (cTNI) have proven useful in identifying cats with myocardial disease but have not been as extensively investigated in hyperthyroidism. Hypothesis: Plasma NT-proBNP and cTNI concentrations are higher in cats with primary cardiac disease than in cats …
-
Structural Mechanism of Cardiac Thin Filament Regulation in Health and Disease: The N-terminus of Cardiac Troponin I as a Therapeutic Target
… Central to this process is cardiac troponin I (cTnI), whose intrinsically disordered N-terminal extension serves as a key regulatory element via phosphorylation at Ser23/24 by protein kinase A (PKA). Although cTnI phosphorylation is known to accelerate myocardial relaxation, the structural …
-
Ανάπτυξη τεχνικών και βιοαντιδραστηρίων ανίχνευσης της τροπονίνης για τη διάγνωση καρδιαγγειακών παθήσεων
… Among the three subunits, cardiac troponin I (cTnI) has the lowest homology to the corresponding skeletal isoforms, which implies increased myocardial specificity. It is also noteworthy that cTnI is more specific for the heart than other established biomarkers, such as CK-MB.When myocardial …
-
Η διαγνωστική αξία της τροπονίνης στην ιατροδικαστική διερεύνηση των πνιγμών εντός θαλασσίου ύδατος
… forensic practice. Elevated cardiac troponin I (cTnI) levels in biological fluids have been associated with myocardial damage, whereas increased Mg2+ and Ca2+ levels were found in cases of saltwater drowning. The aim of this study was to examine the diagnostic utility of postmortem determination …
-
Contribution of troponin-I to the regulation of cardiac muscle
… muscle contraction. The cardiac isoform of TnI (cTnI) has a ~30 residue N-terminal extension, which contains two serines (Ser22/23) that become phosphorylated by protein kinase A upon \(\beta\)-adrenergic stimulation. However, the function of the N-terminus of cTnI remains unclear. Questions also …
Page 1 of 6